NewsBenzingaPharming Affirms FY2026 Sales Guidance of $380.000M-$390.000M vs $383.333M Est Pharming Affirms FY2026 Sales Guidance of $380.000M-$390.000M vs $383.333M Est Benzinga 2026.10.27 08:06 (GMT+0) Open on Benzinga Other news Cathie Wood Says ‘Genius’ Elon Musk is Pushing the World Towards 9% GDP Growth With TSLA, SPCX: ‘We’ve Never Been Here Before’ Dan Ives Says Anthropic Could Eventually Be Worth $3 Trillion Despite Its $80.7 Billion Loss — Insists AI Revolution Is Only in Its ‘Third Inning’ B of A Securities Maintains Buy on MakeMyTrip, Lowers Price Target to $55 UPS Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts Piper Sandler Maintains Overweight on Agilysys, Raises Price Target to $140 Designer Betsey Johnson takes $7 million SoCal home off the market
Cathie Wood Says ‘Genius’ Elon Musk is Pushing the World Towards 9% GDP Growth With TSLA, SPCX: ‘We’ve Never Been Here Before’
Dan Ives Says Anthropic Could Eventually Be Worth $3 Trillion Despite Its $80.7 Billion Loss — Insists AI Revolution Is Only in Its ‘Third Inning’
UPS Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
